Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mallinckrodt Medical OctreoScan

Executive Summary

Side effects and contraindications are absent from a Mallinckrodt journal advertisement and sales aid for imaging agent reviewed by agency, FDA tells company July 22. "The approved product labeling for OctreoScan [kit for the preparation of indium In-111 pentetreotide] includes important warnings and precautions," the letter notes
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS032638

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel